Glucotrack, Inc. Files 8-K with Corporate Updates
Ticker: GCTK · Form: 8-K · Filed: Jan 7, 2025 · CIK: 1506983
Sentiment: neutral
Topics: corporate-governance, filing, amendment
TL;DR
Glucotrack filed an 8-K on Jan 3, 2025, with corporate updates and exhibits.
AI Summary
Glucotrack, Inc. filed an 8-K on January 7, 2025, reporting events as of January 3, 2025. The filing indicates amendments to its Articles of Incorporation or Bylaws, submission of matters to a vote of security holders, and the filing of financial statements and exhibits. The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and has its fiscal year end on December 31.
Why It Matters
This 8-K filing signals potential changes in Glucotrack's corporate structure or governance, which could impact its operational direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain immediate negative financial or operational news.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- Integrity Applications, Inc. (company) — Former company name
- January 3, 2025 (date) — Earliest event reported
- January 7, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific amendments were made to Glucotrack, Inc.'s Articles of Incorporation or Bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What matters were submitted to a vote of Glucotrack, Inc.'s security holders?
The filing states that matters were submitted to a vote, but the nature of these matters is not detailed in the excerpt.
What financial statements and exhibits are being filed with this 8-K?
The filing indicates that financial statements and exhibits are included, but their specific content is not described in the provided text.
When was Glucotrack, Inc. formerly known as Integrity Applications, Inc.?
The company's name changed from Integrity Applications, Inc. to GlucoTrack, Inc. on March 28, 2022.
What is Glucotrack, Inc.'s fiscal year end?
Glucotrack, Inc.'s fiscal year ends on December 31.
Filing Stats: 1,042 words · 4 min read · ~3 pages · Grade level 12.3 · Accepted 2025-01-07 16:05:33
Key Financial Figures
- $0.001 — rized shares of common stock, par value $0.001 per share (the "common stock"), from 10
Filing Documents
- form8-k.htm (8-K) — 52KB
- ex3-1.htm (EX-3.1) — 11KB
- 0001493152-25-001222.txt ( ) — 239KB
- gctk-20250103.xsd (EX-101.SCH) — 3KB
- gctk-20250103_lab.xml (EX-101.LAB) — 33KB
- gctk-20250103_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 7, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer